Clinical Trial Update: Pegteograstim in Children With Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Pegteograstim in pediatric patients with solid tumors undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Solid Tumor

Drugs mentioned

• Pegteograstim (pegteograstim)

Snippet

Sponsor: Samsung Medical Center | Conditions: Chemotherapy Induced Neutropenia, Pediatric Solid Tumor | Phase 2 | Status: UNKNOWN